MMRUBBR_B stock news
This page provides real-time market news, earnings updates, and company announcements related to MM Rubber Co. Ltd. (MMRUBBR_B).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 10:49 IST
Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2025
Finviz2026-02-26 12:48:45
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
Finviz2026-03-04 12:18:02
Vishay Intertechnology RGB LED in 0404 Package Provides Independent Control of Red, True Green, and Blue Chips for Wide Color Range
Finviz2026-03-04 16:03:02
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-05 21:12:18
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
Finviz2026-03-09 11:03:50
Mid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye Disease
Finviz2026-03-09 14:25:01
Navitas Adds Top-Side Cooled QDPAK and Low-Profile TO-247-4L to its Package Line-Up in the Latest 5th Generation GeneSiC Technology
Finviz2026-03-11 12:34:00
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
Finviz2026-03-11 20:12:54
Copa Holdings Announces Monthly Traffic Statistics for February 2026
Finviz2026-03-16 12:36:53
Medtronic OmniaSecure defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing
Finviz2026-03-23 13:03:55
Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Finviz2026-03-24 11:48:42
HP Imagine 2026: HyperX Expands Player Potential for Competitive Play
Finviz2026-03-24 13:33:09
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO) for Relapsed/Refractory Multiple Myeloma
Finviz2026-03-25 11:03:55
Vishay Intertechnology 40 LHE Linear Position Sensor Delivers High Accuracy Displacement Measurement to 40 mm in Harsh Environments
Finviz2026-03-25 15:03:10
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
Finviz2026-03-31 12:06:47
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting
Finviz2026-03-31 12:06:47
Vishay Intertechnology Automotive Grade Photovoltaic MOSFET Driver Boosts Reliability and Lowers Costs in High Voltage Systems
Finviz2026-04-01 15:03:51
Piedmont Realty Trust, Inc. to Report First Quarter 2026 Financial Results
Finviz2026-04-01 20:27:39
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma
Finviz2026-04-02 12:03:43
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Finviz2026-04-06 13:03:55
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
Finviz2026-04-07 10:54:52
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Finviz2026-04-07 11:06:54
Jaguar Health Reports 2025 Financials
Finviz2026-04-07 12:33:46
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
Finviz2026-04-14 12:39:39
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
Finviz2026-03-09 11:03:50
Mid-Cap NovaBridge Biosciences Stock Jumps Fueled By Positive Study Data In Eye Disease
Finviz2026-03-09 14:25:01
Navitas Adds Top-Side Cooled QDPAK and Low-Profile TO-247-4L to its Package Line-Up in the Latest 5th Generation GeneSiC Technology
Finviz2026-03-11 12:34:00
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
Finviz2026-03-11 20:12:54
Copa Holdings Announces Monthly Traffic Statistics for February 2026
Finviz2026-03-16 12:36:53
Medtronic OmniaSecure defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing
Finviz2026-03-23 13:03:55
Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Finviz2026-03-24 11:48:42
HP Imagine 2026: HyperX Expands Player Potential for Competitive Play
Finviz2026-03-24 13:33:09
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO) for Relapsed/Refractory Multiple Myeloma
Finviz2026-03-25 11:03:55
Vishay Intertechnology 40 LHE Linear Position Sensor Delivers High Accuracy Displacement Measurement to 40 mm in Harsh Environments
Finviz2026-03-25 15:03:10
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
Finviz2026-03-31 12:06:47
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting
Finviz2026-03-31 12:06:47
Vishay Intertechnology Automotive Grade Photovoltaic MOSFET Driver Boosts Reliability and Lowers Costs in High Voltage Systems
Finviz2026-04-01 15:03:51
Piedmont Realty Trust, Inc. to Report First Quarter 2026 Financial Results
Finviz2026-04-01 20:27:39
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma
Finviz2026-04-02 12:03:43
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Finviz2026-04-06 13:03:55
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
Finviz2026-04-07 10:54:52
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Finviz2026-04-07 11:06:54
Jaguar Health Reports 2025 Financials
Finviz2026-04-07 12:33:46
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
Finviz2026-04-14 12:39:39
MMRUBBR_B stock price change
On the last trading day, MMRUBBR_B stock closed at 70.00 INR, with a price change of 0.00% for the day.
Trade stock perpsMMRUBBR_B stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more